Skip to content

The Impact of Obesity on Postoperative Outcomes Following Cardiac Surgery

The Impact of Obesity on Postoperative Outcomes Following Cardiac Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03248921
Acronym
OPOS
Enrollment
610
Registered
2017-08-15
Start date
2014-11-30
Completion date
2030-11-30
Last updated
2021-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Disease, Cardiovascular Syndromes, Metabolic, Obesity

Brief summary

The purpose of this study is to identify measures of obesity, functional capacity, and specific biomarkers that may be predictive of obesity and post-operative outcomes.

Detailed description

Background: Increasing levels of obesity worldwide have led to a rise in the prevalence of obesity-related complications including cardiovascular disease, diabetes, cancers etc. Health care providers believe that obesity has a negative effect on patients undergoing cardiac surgery, with overweight and obese patients being more likely to experience adverse post-operative outcomes. The body mass index (BMI) is the single most used measure for determining obesity classification in clinical practice, without accounting for a patient's level of cardiopulmonary fitness or muscle mass. Study Design: Patients between the ages of 18 and 75 years undergoing elective cardiac surgery will be consented to participate in this prospective observational trial. Patients are invited to participate in measures of obesity, functional capacity and exercise capacity assessments, quality of life questionnaires, and blood and tissue sampling for biomarker analysis. Endpoints: Measures other than BMI that could be predictive of short-term and long-term post-operative outcomes. Outcomes of interest include: prolonged length of ventilation, hospital length of stay and all-cause mortality. Summary: The results of this trial will potentially identify an improved definition of fitness capacity for obese cardiac surgical patients and biomarkers alone or in combination that could identify the potential for adverse outcomes in patients undergoing cardiac surgery. This study will help clinicians better segregate and treat patients pre-operatively based on fitness levels and associated biomarkers.

Interventions

PROCEDUREcardiac surgery

cardiac surgery including non-emergency, elective coronary artery bypass grafting surgery with or without valve surgery, aortic or mitral valve surgery

Sponsors

Horizon Health Network
CollaboratorOTHER
Maritime Heart Centre
CollaboratorOTHER
Cardiovascular Research New Brunswick
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* · Provide informed consent * Male or female patients who are \> 18 years of age * Patients must be scheduled to undergo elective, first-time cardiac surgery during routine scheduling times

Exclusion criteria

* Patients who are \> 75 years of age * BMI is less than 18.5 kg/m2 and classified as underweight according to the World Health Organization * Any non-elective first time cardiac surgery patient (eg. in-house urgent patients; emergent patients) * Any cardiac patients to undergo re-operation * Simultaneous participation in another study with an investigational study agent

Design outcomes

Primary

MeasureTime frameDescription
Prolonged Hospitalizationpost-operative day (POD) 30A length of stay of more than 5 days
Prolonged ventilation > 24 hourspost-operative day (POD) 30mechanical ventilation for more than 24 hours of invasive (via endotracheal tube or tracheostomy) and/or noninvasive (facial/nasal interface) methods of delivery

Secondary

MeasureTime frameDescription
non fatal myocardial infarctionpost-operative day (POD) 30 and 1 year post-opTransmural, Subendocardial infarction
Strokepost-operative day (POD) 30Transient, permanent
all cause mortalitypost-operative day (POD) 30 and 1 year post-opPatient death, either in hospital or long-term
Respiratory complicationspost-operative day (POD) 30Pleural effusion, pneumonia
Atrial fibrillationpost-operative day (POD) 30 and 1 year post-oppost-op occurrence requiring treatment
Post-operative length of stay and disposition on dischargepost-operative day (POD) 30 and 1 year post-ophome, home with care, transfer to other facility, or expired
Wound infectionpost-operative day (POD) 30infection of sternum or other incisional access sites
Re-operation for any causepost-operative day (POD) 30 and 1 year post-opre-operation due to complications, bleeding and/or other reasons
Prolonged ICU length of staypost-operative day (POD) 30length of stay of more than 48 hours

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026